Pasithea Therapeutics (KTTA) Goodwill & Intangibles (2022 - 2026)

Pasithea Therapeutics has reported Goodwill & Intangibles for 5 years, with the latest figure at $3.6 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 63.16% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 63.16% YoY) and the FY2025 annual result came in at $8.6 million, changed 0.03% from the prior year.
• Goodwill & Intangibles declined to $3.6 million in Q1 2026 per KTTA's latest filing, from $8.6 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $9.8 million in Q4 2022 and troughed at $3.6 million in Q1 2026.
• A 5-year average of $8.3 million and a median of $9.4 million in 2023 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2023 and 2026: Goodwill & Intangibles jumped 148.32% in 2023, then slumped 63.16% in 2026.
• Over 5 years, Goodwill & Intangibles stood at $9.8 million in 2022, then changed by 0.0% to $9.8 million in 2023, then fell by 12.82% to $8.6 million in 2024, then fell by 0.03% to $8.6 million in 2025, then slumped by 57.73% to $3.6 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $3.6 million, $8.6 million, and $9.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.